Your browser doesn't support javascript.
loading
The protective effects of SGLT-2 inhibitors, GLP-1 receptor agonists, and RAAS blockers against renal injury in patients with type 2 diabetes.
Kuang, Zengguang; Hou, Ningning; Kan, Chengxia; Han, Fang; Qiu, Hongyan; Sun, Xiaodong.
Afiliação
  • Kuang Z; Department of Endocrinology and Metabolism, Affiliated Hospital of Weifang Medical University, 2428 Yuhe Road, Weifang, 261031, Shandong, China.
  • Hou N; Branch of Shandong Provincial Clinical Research Center for Diabetes and Metabolic Diseases, Weifang, China.
  • Kan C; Clinical Research Center, Affiliated Hospital of Weifang Medical University, Weifang, China.
  • Han F; Department of Endocrinology and Metabolism, Affiliated Hospital of Weifang Medical University, 2428 Yuhe Road, Weifang, 261031, Shandong, China.
  • Qiu H; Branch of Shandong Provincial Clinical Research Center for Diabetes and Metabolic Diseases, Weifang, China.
  • Sun X; Department of Endocrinology and Metabolism, Affiliated Hospital of Weifang Medical University, 2428 Yuhe Road, Weifang, 261031, Shandong, China.
Int Urol Nephrol ; 55(3): 617-629, 2023 Mar.
Article em En | MEDLINE | ID: mdl-36036316

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Nefropatias Diabéticas / Inibidores do Transportador 2 de Sódio-Glicose Limite: Humans Idioma: En Revista: Int Urol Nephrol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Nefropatias Diabéticas / Inibidores do Transportador 2 de Sódio-Glicose Limite: Humans Idioma: En Revista: Int Urol Nephrol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China